Skip to main content
Fig. 1 | BMC Cancer

Fig. 1

From: CD44, TGM2 and EpCAM as novel plasma markers in endometrial cancer diagnosis

Fig. 1

Concentrations of biomarkers in plasma. a EpCAM concentration in EC vs. non-EC samples: median 44.99 (95% CI 34.80–49.08) vs. 28.67 (95% CI 23.93–35.79), (U = 489.50, Z = 2.2, p = 0.028). b TGM2 concentration in EC vs. non-EC samples: median 4808.36 (95% CI 3688.71–6224.69) vs. 1828.96 (95% CI 1574.94–3028.34), (U = 316, Z = 2.85, p = 0.004). c CA9 concentration in EC vs. control vs. endometriosis (ENDOM) samples. d CD44 concentration in EC vs. control vs. endometriosis samples. e EpCAM concentration in EC vs. control vs. endometriosis samples. f TGM2 concentration in EC vs. control samples vs. endometriosis samples. * p < 0.05, ** p < 0.01, *** p < 0.001

Back to article page